| Net income (loss) | 593K |
| Depreciation and amortization | 3.16M |
| Provision for doubtful accounts | |
| Deferred income taxes | |
| Excess tax benefits from stock options | -192K |
| Stock-based compensation expense | 1.04M |
| Amortization of marketable securities (premiums) discounts, net | |
| Loss on sale of marketable securities | |
| Fair value adjustment of contingent earnout consideration | |
| Accounts receivable | -208K |
| Prepaid expenses and other current assets | -701K |
| Accounts payable and accrued liabilities | |
| Accrued payroll and related liabilities | |
| Deferred revenue and other liabilities | |
| Net cash provided by (used in) operating activities | |
| Changes in restricted cash | |
| Redemptions of marketable securities | |
| Capitalization of product development costs | |
| Acquisition of Meridian Consulting International | |
| Acquisition of Fullscope, Inc. | |
| Purchases of property and equipment | -327K |
| Net cash (used in) provided by investing activities | |
| Payments on capital leases | |
| Excess tax benefits from stock options | |
| Proceeds from employee stock plans and stock option exercises | 2.4M |
| Net cash provided by financing activities | |
| Effects of exchange rates on cash | 43K |
| Net increase in cash and cash equivalents | 166K |
| CASH AND CASH EQUIVALENTS, beginning of period | 11.98M |
| CASH AND CASH EQUIVALENTS, end of period | 12.15M |
| Cash paid for income taxes | 215K |
| Unrealized loss on securities | |
| Net issuances and forfeitures of restricted stock awards | |